LINGOOD
833284
HENDERA
831152
WANDA BEARING
920002
4
VIBO
871245
5
WUHAN LAND
830779
US Stock MarketDetailed Quotes
CNBX CNBX Pharmaceuticals
- 0.009000
- 0.0000000.00%
15min DelayClose Feb 25 12:25 ET
280.00KMarket Cap-0.60P/E (TTM)
0.000000High0.000000Low18Volume0.005400Open0.009000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)31.11MShares0.01990052wk High-0.11P/B273.47KFloat Cap0.00500052wk Low--Dividend TTM30.39MShs Float27.960000Historical High--Div YieldTTM0.00%Amplitude0.005000Historical Low0.000000Avg Price1Lot Size
CNBX Pharmaceuticals Key Stats
EPS
According to the latest financial report of CNBX Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about CNBX Pharmaceuticals's free cash flow? The latest report shows it as -39.08K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CNBX Pharmaceuticals shows that the company's current ratio is 0.01, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CNBX Pharmaceuticals, the quick ratio is 0.01, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of CNBX Pharmaceuticals? The latest ROE figure is -108.74%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CNBX Pharmaceuticals, the total asset return on investment (ROA) is -127.96%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check CNBX Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 84.69%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CNBX Pharmaceuticals, the net profit margin is -800.89%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call